Investment Thesis — Air Products and Chemicals, Inc.
The market is mispricing Air Products and Chemicals by fixating on recent negative EPS and short-term underperformance, overlooking the essential, recurring nature of its industrial gas business and the robust earnings recovery implied by its forward valuation. We believe the current price offers an entry point before the market fully appreciates the rebound in core profitability.
Catalysts
- Strong Q1/Q2 earnings report showing positive EPS and robust guidance.
- Major new project announcements, especially in clean energy/hydrogen infrastructure.
- Positive analyst upgrades and increased institutional buying as earnings visibility improves.
Risk Factors
- Prolonged global industrial slowdown impacting demand for gases across key sectors.
- Higher-than-expected capital expenditures or project delays eroding profitability and cash flow.
- Unexpected competitive pressure or technological disruption in key industrial gas markets.
Key Debates
Net Margin turns positive by Q3 2024, re-rating Fwd P/E.
Debt-fueled projects accelerate revenue growth to 6%+ by H1 2025.
ROE turns positive by Q4 2024, validating P/B multiple.